Chronic obstructive pulmonary disease and a new phenotype of lung function impairment predicted progression of frailty in older adults, based on data from more than 5000 individuals. COPD has been ...
Middle-aged or older adults with a prefrail or frail status had a significantly higher risk for incident dementia than those with a robust status. The risk for dementia rose sharply in participants ...
Frailty progression was associated with fewer days alive at home (DAH), regardless of age or frailty level at baseline, a new study shows. Compared with people with frailty regression, people with ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients with preserved ratio impaired spirometry (PRISm ...
Many countries have become super-aged societies, with 20% of their populations being over 65 years old 1; South Korea is expected to become a super-aged society by 2025 2. As the global older ...
2023 JUN 14 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- New research on Science is the subject of a report. According to news reporting originating in Seoul, South Korea ...
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors-such as empagliflozin (Jardiance) and dapagliflozin (Farxiga)-or ...
Nov. 16 (UPI) --Wearable devices may provide the answer to working out which older adults are at future risk of frailty-related health complications by tracking their circadian rhythms, results from a ...
Frailty is a geriatric syndrome characterized by a declined physiological reserve and an increased vulnerability for adverse outcomes 1. With the global population rapidly aging, frailty has become a ...
Identifying adults at high risk of frailty and implementing appropriate interventions are critical for extending healthy life expectancy. To examine whether abdominal obesity predicts frailty ...
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors—such as empagliflozin (Jardiance) and dapagliflozin (Farxiga)—or ...